Please ensure Javascript is enabled for purposes of website accessibility
Home / Opinion / Commentary / Consumers, small businesses, taxpayers need relief from Big Pharma

Consumers, small businesses, taxpayers need relief from Big Pharma

According to a study conducted by Avik Roy and Gregg Girvan of the Foundation for Research on Equal Opportunity (FREOPP), Big Pharma’s abuse of the patent system around biologic drugs, such as Humira, cost American patients and taxpayers an additional $5 billion between 2015 and 2020. Without congressional action to hold brand name drug companies accountable, the report estimates this anti-competitive behavior around just this one class of drug will cost the American people another $25 billion by the end of the decade.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

x

Check Also

Ban assault weapons, not drag queens (access required)

Allow me to make a common sense assumption that should be reflected by common sense policy: assault weapons pose a greater danger to children than drag queens. 

/* code for tag simpli.fi */